Sanara MedTech报告Q4结果

2024-03-26 04:35

Sanara MedTech press release (NASDAQ:SMTI): Q4 Revenue of $17.7M beats by $1.2M.
The Company had a net loss of $0.3 million, compared to a net loss of $4.2 million for the three months ended December 31, 2022.

More on Sanara MedTech

Sanara MedTech announces exclusive license agreement for patented collagen peptides
Seeking Alpha’s Quant Rating on Sanara MedTech
Historical earnings data for Sanara MedTech
Financial information for Sanara MedTech